Skip to main content
Log in

An evaluation of clinical follow-up in women with early stage breast cancer among physician members of the American Society of Clinical Oncology

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Routine clinical follow-up for distant metastatic disease among women with early stage breast cancer is of uncertain clinical benefit. In order to evaluate current practice patterns, we administered a mailed survey to a stratified random sample of physician members of the American Society of Clinical Oncology (ASCO) (N = 435). The survey assessed the frequency and motivation for ordering follow-up medical tests in asymptomatic postmenopausal women with stage I or II breast cancer. The response rate was 55%, distributed as 39% radiation oncologists, 32% medical oncologists, and 29% surgeons. In the first year after treatment, physicians performed, on average, one physical examination every 3 months, one blood panel (CBC, alkaline phosphatase and liver function tests) every 4 months, and one chest radiograph every 9 months. In addition, 38% of the respondents ordered CEA and 21% ordered CA 15-3 levels, 28% ordered bone scans, and less than 4% ordered CT scans, bone surveys, or bone marrow biopsies in the first year after treatment. A logistic regression analysis controlling for physician age, gender, sub-specialty, practice type, years of experience, number of breast cancer patients treated annually, geographic region, and community size, showed that surgeons were less likely to order blood tests (p < 0.001) and tumor markers (p < 0.0029) than medical oncologists in years 3 and 5 of follow-up. Compared to physicians practicing in the northeast, those from the midwest were less likely to order chest radiographs in year 3 of follow-up (p = 0.0028). Other provider characteristics had no significant effect on test ordering behavior. The results of this survey suggest that relatively uniform practice patterns in regard to the follow-up of postmenopausal women with early stage breast cancer exist among ASCO physicians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fowble B, Goodman RL, Glick JH, Rosato EF: Breast cancer treatment. A comprehensive guide to management. Mosby-Year Book, Inc., St. Louis, 1991, Chapter 16, pp 403–419

    Google Scholar 

  2. Division of Cancer Prevention and Control. Cancer statistics review 1973–1988. Bethesda, MD: US Department of Health and Human Services. National Cancer Institute. 1991 (NIH Publication No. 91-2789)

  3. Donegan WL, Spratt JS (eds): Cancer of the Breast. Third edition. W.B. Saunders, Philadelphia, 1988, Chapter 6, pp 125–167

    Google Scholar 

  4. Brinkley D, Haybittle JL: Long term survival of women with breast cancer. Lancet i: 1118, 1984

    Google Scholar 

  5. Swartz M: Summary: A model of screening for breast cancer. Presented at the Michigan Cancer Foundation Workshop, Detroit, 1977 May

  6. Frazier TG, Copeland EM, Gallagher HS, Paulus DD, White EC: Prognosis and treatment in minimal breast cancer. Am J Surg 133: 697–701, 1977

    Google Scholar 

  7. Greenwald P, Sondik E (eds): Cancer Control Objectives for the Nation: 1985–2000. NCI Monographs 2: 27, 1986

  8. Duncan W, Kerr GR: The curability of breast cancer. Br Med J ii: 781–783, 1976

    Google Scholar 

  9. Schapira DV, Urban N: A minimalist policy for breast cancer surveillance. JAMA 265: 380–382, 1991

    Google Scholar 

  10. Loomer L, Brockschmidt JK, Muss HB, Saylor G: Postoperative follow-up of patients with early breast cancer. Cancer 67: 55–60, 1991

    Google Scholar 

  11. Kamby C, Vejborg I, Kristensen B, Olsen LO, Mouridsen HT: Metastatic pattern in recurrent breast cancer. Cancer 62: 2226–2233, 1988

    Google Scholar 

  12. Harris JR, Hellman S, Henderson IC, Kinne DW: Breast Diseases. Second Edition. JB Lippincott, Philadelphia, 1991, Chapter 19, pp 505–525

    Google Scholar 

  13. Wagman LD, Sanders RD, Terz JJ, Beatty JD, Kokal WA, Riihimaki DU: The value of symptom directed evaluation in the surveillance for recurrence of carcinoma of the breast. Surg Gynecol Obstet 172: 191–196, 1991

    Google Scholar 

  14. Hietanen P: Chest radiography in the follow-up of breast cancer. Acta Radiol Oncol 25: 15–18, 1986

    Google Scholar 

  15. Hughes LE, Courtney SP: Follow up of patients with breast cancer. Br Med J 290: 1229–1230, 1985

    Google Scholar 

  16. Arnstein NB, Harbert JC, Byrne PJ: Efficacy of bone and liver scanning in breast cancer patients treated with adjuvant chemotherapy. Cancer 54: 2243–2247, 1984

    Google Scholar 

  17. Pandya J, McFadden ET, Kalish LA, Tormey DC, Taylor SG, Falkson G: A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group Adjuvant chemotherapy trials for breast cancer. Cancer 55: 202–205, 1985

    Google Scholar 

  18. Marrazzo A, Solina G, Puccia V, Fiorentino E, Bazan P: Evaluation of routine follow-up after surgery for breast carcinoma. J Surg Oncol 32: 179–181, 1986

    Google Scholar 

  19. Ojeda MB, Alonso MC, Bastus R, Alba E, Piera JM, Lopez JJ: Follow-up of breast cancer stages I and II. An analysis of some common methods. Eur J Clin Oncol 23: 419–423, 1987

    Google Scholar 

  20. Schunemann H, Langecker PJ, Ellgas W, Leonhardt A, Merkl H: Value of bone scanning in the follow-up of breast cancer patients. J Cancer Res Clin Oncol 116: 486–491, 1990

    Google Scholar 

  21. Eiseman B, Feiner AS: Cost-effective followup of the cancer patient. Postgraduate Medicine 83: 119–126, 1988

    Google Scholar 

  22. Thomsen HS, Rasmussen D, Munck O, Lund JO, Gerhard-Nielsen V, Terkildsen Tet al.: Bone metastases in primary operable breast cancer. The role of yearly scintigraphy. Eur J Cancer Clin Oncol 23: 779–781, 1987

    Google Scholar 

  23. Baker RR, Holmes ER, Anderson POet al. An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer. Ann Surg 186: 363–368, 1977

    Google Scholar 

  24. Burkett FE, Scanlon EF, Garces RM, Khanderkar JDL: The value of bone scans in the management of patients with carcinoma of the breast. Surg Gynecol Obstet 149: 523–525, 1979

    Google Scholar 

  25. McNeil B, Pace PD, Gray Eet al.: Pre-operative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet 147: 745–748, 1978

    Google Scholar 

  26. Wickerham L, Fisher B, Cronin Wet al.: The efficacy of bone scanning in the follow-up of patients with operable breast cancer. Breast Cancer Res Treat 1: 24–84, 1983

    Google Scholar 

  27. Pedrazzini A, Gelbes R, Isley Met al.: First repeated bone scan in the observation of patients with operable breast cancer. J Clin Oncol 4: 389–394, 1986

    Google Scholar 

  28. Scanlon EF, Ovieda MA, Cunningham MP, Caprim JA, Khandekan JD, Cohen Eet al.: Preoperative and follow-up procedures on patients with breast cancer. Cancer 46: 977–979, 1980

    Google Scholar 

  29. Broyn T, Froyen J: Evaluation of routine follow-up after surgery for breast cancer. Acta Chir Scand 148: 401–404, 1982

    Google Scholar 

  30. Winchester DP, Sener SF, Khandekar JD, Oriedo MA, Cunningham MP, Caprini JAet al.: Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer 43: 956–960, 1979

    Google Scholar 

  31. Perez D, Milan J, Powles Tet al.: Detection of breast carcinoma metastases in bone: relative merits of x-rays and skeletal scintigraphy. Lancet 2: 613–616, 1983

    Google Scholar 

  32. Rossing N, Munck O, Nielsen Set al.: What do early bone scans tell about breast cancer patients? Eur J Cancer Clin Oncol 18: 629–636, 1982

    Google Scholar 

  33. Concoran RJ, Thrall JH, Kyle RWet al.: Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 121: 663–667, 1976

    Google Scholar 

  34. Turner DTL, Ackery D, Fraser JD, Chaut ADB: The bone scan - has annual screening a place in the follow-up of breast cancer patients? Clin Oncol 3: 126–127, 1977

    Google Scholar 

  35. Cantwell B, Fennelly JJ, Jones M: Evaluation of follow-up methods to detect relapse after mastectomy in breast cancer patients. Ir J Med Sci 151: 1–5, 1982

    Google Scholar 

  36. Vestergaard A, Herrstedt J, Thomsen HS, Dombernowsky P, Zedeler K: The value of yearly chest x-ray in patients with stage I breast cancer. Eur J Cancer Clin Oncol 25: 687–689, 1989

    Google Scholar 

  37. Ormiston MC, Timoney AG, Qureshi AR: Is follow up of patients after surgery for breast cancer worthwhile? J Royal Soc Med 78: 920–921, 1985

    Google Scholar 

  38. Rutgers EJ, van Slooten EA, Kluck HM: Follow-up after treatment of primary breast cancer. Br J Surg 76: 187–190, 1989

    Google Scholar 

  39. Mansi JL, Earl HM, Powles TJ, Coombes RC: Tests for detecting recurrent disease in the follow-up of patients with breast cancer. Breast Cancer Res Treat 11: 249–254, 1988

    Google Scholar 

  40. Wiener SN, Sachs SH: An assessment of routine liver scanning in patients with breast cancer. Arch Surg 113: 126–127, 1978

    Google Scholar 

  41. Ingle JN, Tormey DC, Tan HK: The bone marrow examination in breast cancer. Diagnostic considerations and clinical usefulness. Cancer 41: 670–674, 1978

    Google Scholar 

  42. ASCO Membership Directory 1991. American Society of Clinical Oncology, 1991

  43. U.S. Bureau of the Census, Statistical Abstract of the United States: (III edition) Washington, D.C., 1991

  44. SAS/STAT User's Guidelines, SAS Institute Inc., Cary, 1988, p 189

  45. Breslow NE, Day NE: Statistical methods in cancer research. International Agency for Research on Cancer, Lyon, 1980, Chapter 6, p. 192–248

    Google Scholar 

  46. Dunnett CW: A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50: 1096–1121, 1955

    Google Scholar 

  47. Tomin R, Donnegan WL: Screening for recurrent breast cancer - its effectiveness and prognostic value. J Clin Oncol 5: 62–67, 1987

    Google Scholar 

  48. Muss HB, McNamara MJC, Connelly RA: Follow-up after stage II breast cancer: A comparative study of relapsed versus non-relapsed patients. Am J Clin Oncol 4: 451–455, 1988

    Google Scholar 

  49. Kunkler IH, Merrick MV: The value of non-staging skeletal scintigraphy in breast cancer. Clinical Radiology 37: 561–562, 1986

    Google Scholar 

  50. Gerber FH, Goodreau JJ, Kirchner PT, Fouty WJ: Efficacy of preoperative and postoperative bone scanning in the management of breast cancer. N Engl J Med 297: 300–303, 1977

    Google Scholar 

  51. Khanderkar JD, Burkett FE, Scanlon EF: Sensitivity, specificity and predictive value of bone scans in breast cancer. Abstract. Proc Soc Clin Oncol 19: 379, 1978

    Google Scholar 

  52. Zwaveling A, Albers GHR, Felthuis W, Hermans J: An evaluation of routine follow-up for detection of breast cancer recurrences. J Surg Oncol 34: 194–197, 1987

    Google Scholar 

  53. Wertheimer MD: Commentary. Against minimalism in breast cancer follow-up. JAMA 265: 396–397, 1991

    Google Scholar 

  54. Johnston FRC: Adverse effect of postoperative irradiation on the breast. Adv Med Oncol Res Education 12: 401, 1978

    Google Scholar 

  55. Horton J: Follow-up of breast cancer patients. Cancer 53: 790–797, 1984

    Google Scholar 

  56. Commission on Cancer, American College of Surgeons: The patient with cancer: Guidelines for follow-up, p 60, 1976

  57. Brown ML: The national economic burden of cancer: An update. JNCI 82: 1811–1814, 1990

    Google Scholar 

  58. Baker MS, Kessler LG, Urban N, Smucker RC: Estimating the treatment costs of breast and lung cancer. Medical Care 29: 40–49, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simon, M.S., Hoff, M., Hussein, M. et al. An evaluation of clinical follow-up in women with early stage breast cancer among physician members of the American Society of Clinical Oncology. Breast Cancer Res Tr 27, 211–219 (1993). https://doi.org/10.1007/BF00665691

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00665691

Key words

Navigation